脊柱用生物製剤の世界市場:同種移植片、幹細胞、BMP、DBM、合成移植骨

◆英語タイトル:Global Spine Biologics Market 2016-2020
◆商品コード:IRTNTR9386
◆発行会社(調査会社):Technavio
◆発行日:2016年6月8日
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、脊柱用生物製剤の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、脊柱用生物製剤の世界市場規模及び予測、製品別分析、市場シェア、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About the Spine Biologics Market
The global spine biologics market has seen an ideal shift in the past few years. The market is witnessing growth because of the developments and adoption of spine biologic by end-users.
The market is driven by factors such as the increase in older adult population and growing incidence of spinal disorders such as herniated discs, degenerative disc disease, spondylolisthesis, prolapsed intervertebral disc, and spinal stenosis. A shift in preference for MI surgeries over open surgeries has led to the development of technologically advanced spinal implants, which leads to an increased demand for spine biologics. An increasing number of lumbar fusion procedures being performed, and rising popularity among the younger and active patient population to retain some movement and flexibility, are some of the trends currently being witnessed in the market.

Technavio’s analysts forecast the global spine biologics market to grow at a CAGR of 2.07% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global spine biologics market for 2016-2020. To calculate the market size, we consider the revenue generated from the sales of the following:
• Allograft
• Stem cells
• Bone morphogenetic proteins (BMPs)
• Demineralized bone matrix (DBM)
• Synthetic bone grafts

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Spine Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• SeaSpine

[Other prominent vendors]
• Alphatec Spine
• AMEDICA
• Anika Therapeutics
• Arthrex
• Baxter
• Berkeley Advanced Biomaterial
• Biomimetic Therapeutics
• Globus Medical
• Integra Life Sciences
• ISTO Technologies
• K2M
• LDR
• Orthofix International
• RTI Surgical
• Xtant Medical

[Market driver]
• Growing popularity of MI spinal and robot-assisted surgeries
• For a full, detailed list, view our report

[Market challenge]
• Complications associated with spine implants in spine surgeries
• For a full, detailed list, view our report

[Market trend]
• Emerging MI sacroiliac joint fusion technique
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Spine biologics: An overview
• Clinical need for biologics in spine surgeries
• Funding in spine biologics
• Spine biologic products under clinical trials

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by product
• Allograft
• Stem cells
• BMP
• DBM
• Synthetic bone grafts

PART 08: Global spine biologics market by allograft
• Market size and forecast

PART 09: Global spine biologics market by stem cells
• Market overview
• Market size and forecast

PART 10: Global spine biologics market by BMP
• Market overview

PART 11: Global spine biologics market by DBM
• Market overview
• Market size and forecast

PART 12: Global spine biologics market by synthetic bone grafts
• Market overview

PART 13: Geographical segmentation
• Spine biologics market in Americas
• Spine biologics market in EMEA
• Spine biologics market in APAC

PART 14: Key leading countries
• US
• Japan
• Germany

PART 15: Market drivers
• Increased incidence of spinal disorders
• Growing popularity of MI spinal and robot-assisted surgeries
• Rise in strategic partnerships for marketing
• Increase in older population

PART 16: Impact of drivers

PART 17: Market challenges
• Complications associated with spine implants in surgeries
• Stringent regulatory and reimbursement policies
• High cost of spinal fusion surgery
• Intense competition
• Poor performance of bone graft substitute

PART 18: Impact of drivers and challenges

PART 19: Market trends
• Advances in technology
• Rise in popularity of physician-owned ASCs
• Emerging MI sacroiliac joint fusion technique
• Product development in collaboration with research institutes
• Increase in M&A

PART 20: Vendor landscape
• Competitive scenario
• Market share analysis
• Medtronic
• Johnson & Johnson
• Stryker
• NuVasive
• Zimmer Biomet
• SeaSpine
• Other prominent vendors

PART 21: Appendix
• List of abbreviations

PART 22: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Spine fusion techniques
Exhibit 03: Funding for development of spine biologics
Exhibit 04: List of spine biologic products under clinical trials
Exhibit 05: Spine market model 2015
Exhibit 06: Global spine biologics market 2015-2020 ($ billions)
Exhibit 07: Five forces analysis
Exhibit 08: Segmentation of global spine biologics market by product type
Exhibit 09: Global spine biologics market segmentation by product type 2015
Exhibit 10: Global spine biologics market by allografts 2015-2020 ($ millions)
Exhibit 11: Global spine biologics market by stem cells 2015-2020 ($ millions)
Exhibit 12: Global spine biologics market by BMP 2015-2020 ($ millions)
Exhibit 13: Global spine biologics market by DBM 2015-2020 ($ millions)
Exhibit 14: Global spine biologics market by synthetic bone grafts 2015-2020 ($ millions)
Exhibit 15: Segmentation of global spine biologics market by product type 2015-2020 ($ millions)
Exhibit 16: Segmentation of global spine biologics market by product type 2015-2020 (%)
Exhibit 17: Global spine biologics market by geography 2015
Exhibit 18: Global spine biologics market by geography 2020
Exhibit 19: Spine biologics market in Americas 2015-2020 ($ billions)
Exhibit 20: Spine biologics market in EMEA 2015-2020 ($ millions)
Exhibit 21: Spine biologics market in APAC 2015-2020 ($ millions)
Exhibit 22: Global spine biologics market by geography 2015-2020 ($ millions)
Exhibit 23: Global spine biologics market by geography 2015-2020
Exhibit 24: Population aged 60 years and above: World, developed, and developing regions 1950-2050 (millions)
Exhibit 25: Impact of drivers
Exhibit 26: Comparison of the cost of spine surgeries 2015
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Ranking of top six vendors 2015
Exhibit 29: Market share of vendors 2015
Exhibit 30: Collaboration between vendors and universities or organizations
Exhibit 31: Medtronic: Product portfolio
Exhibit 32: Medtronic: Restorative Therapies group by revenue 2013-2015 ($ billions)
Exhibit 33: Medtronic: Key takeaways
Exhibit 34: Johnson & Johnson: Product portfolio
Exhibit 35: Johnson & Johnson: Key takeaways
Exhibit 36: Stryker: Product portfolio
Exhibit 37: Stryker: Orthopedics segment by revenue 2013-2015 ($ billions)
Exhibit 38: Stryker: Key takeaways
Exhibit 39: NuVasive: Product portfolio
Exhibit 40: NuVasive: Biologics segment by revenue 2013-2015 ($ millions)
Exhibit 41: NuVasive: Key takeaways
Exhibit 42: Zimmer Biomet: Product portfolio
Exhibit 43: Zimmer Biomet: Key takeaways
Exhibit 44: SeaSpine: Product portfolio
Exhibit 45: SeaSpine: Orthopedics segment by revenue 2013-2015 ($ millions)
Exhibit 46: SeaSpine: Key takeaways
Exhibit 47: Other prominent vendors



【掲載企業】

Medtronic, Johnson & Johnson, Stryker, NuVasive, Zimmer Biomet, SeaSpine, Alphatec Spine, AMEDICA, Anika Therapeutics, Arthrex, Baxter, Berkeley Advanced Biomaterial, Biomimetic Therapeutics, Globus Medical, Integra Life Sciences, ISTO Technologies, K2M, LDR, Orthofix International, RTI Surgical, Xtant Medical.

【レポートのキーワード】

脊柱用生物製剤、同種移植片、幹細胞、BMP、DBM、合成移植骨

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[脊柱用生物製剤の世界市場:同種移植片、幹細胞、BMP、DBM、合成移植骨]販売に関する免責事項
★調査レポート[脊柱用生物製剤の世界市場:同種移植片、幹細胞、BMP、DBM、合成移植骨]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆